Valuation: Avantor, Inc.

Market Cap 10.34B 9.13B 8.63B 7.83B 14.68B 992B 14.83B 104B 39.92B 507B 38.83B 37.99B 1,631B P/E 2026 *
45.8x
P/E 2027 * 32.8x
Enterprise Value 13.4B 11.83B 11.19B 10.15B 19.03B 1,286B 19.22B 134B 51.75B 657B 50.34B 49.24B 2,114B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.89x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 57 21/09/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 10.34B
-0.43%-3.40%-24.75%+3.42% 175B
-2.77%-4.65%-7.90%+10.45% 114B
+0.13%-3.36%-1.36%+68.84% 57.98B
-1.41%-1.02%-1.56%-29.94% 50.07B
-1.00%+2.74%+13.85%+53.00% 50.13B
-0.66%-3.82%+29.57%-7.71% 32.71B
-0.60%+1.18% - - 30.77B
-0.17%+0.90%+43.84%-0.21% 26.44B
+0.28%+5.23%+26.98%-3.89% 23.96B
Average -0.69%+1.59%+9.83%+11.74% 62.36B
Weighted average by Cap. -1.05%-0.18%-3.62%+12.42%

Financials

2026 *2027 *
Net sales 6.59B 5.82B 5.51B 4.99B 9.36B 633B 9.45B 66.04B 25.45B 323B 24.76B 24.22B 1,040B 6.75B 5.96B 5.64B 5.11B 9.58B 648B 9.68B 67.6B 26.05B 331B 25.34B 24.79B 1,064B
Net income 225M 199M 188M 170M 320M 21.6B 323M 2.26B 869M 11.03B 845M 827M 35.5B 311M 274M 259M 235M 441M 29.82B 446M 3.11B 1.2B 15.23B 1.17B 1.14B 49B
Net Debt 3.06B 2.7B 2.56B 2.32B 4.35B 294B 4.39B 30.68B 11.83B 150B 11.5B 11.25B 483B 2.42B 2.14B 2.02B 1.83B 3.44B 232B 3.47B 24.27B 9.35B 119B 9.1B 8.9B 382B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-